產(chǎn)品搜索
相關(guān)文章
- 從“腫瘤免疫療法”發(fā)展,看“單抗、CAR-T”任重而道遠(yuǎn)!
- 你知道ATCC細(xì)胞如何解凍嗎?
- 是激活還是沉默?基因表達(dá)的新路徑
- 【產(chǎn)品推介】T細(xì)胞活化篩選模型
- 為什么STR鑒定對于ATCC細(xì)胞系來說很重要
- 喝熱茶或使食管癌風(fēng)險(xiǎn)增加5倍
- PIM-1激酶抑制劑細(xì)胞篩選模型
- ANG TIE2:重塑千億血管靶向治療市場,“血管-免疫”協(xié)同治療革命
- PNAS:腫瘤細(xì)胞或可“拆用”間充質(zhì)干細(xì)胞來促進(jìn)乳腺癌復(fù)發(fā)
- 腫瘤細(xì)胞分裂“制動系統(tǒng)”相關(guān)基因分析
聯(lián)系我們
電話:4008750250
號碼:
手機(jī):18066071954
地址:南京市棲霞區(qū)緯地路9號
Email: zhangxiangwen@cobioer.com
產(chǎn)品展示 / PRODUCTS
藥靶細(xì)胞株 > kinase激酶細(xì)胞株 > CBP73253CSF3R T618I/BaF3

- 詳細(xì)內(nèi)容
CBP73253 | |
I. Introduction | |
Cell Line Name: | CSF3R T618I/BaF3 |
Host Cell: | Ba/F3 |
Stability: | 16 passages (in-house test, that not means the cell line will be instable beyond the passages we tested.) |
Application: | Anti-proliferation assay and PD assay |
Freeze Medium: | 90% FBS+10% DMSO |
Complete Culture Medium: | RPMI-1640+10%FBS |
Mycoplasma Status: | Negative |
II.Background | |
CSF3R T618I lies within the extracellular domain proximal to the transmembrane domain of the Csf3r protein (PMID: 23656643). T618I confers a gain of function to the Csf3r protein as demonstrated by increased proliferation and increased downstream Jak-Stat signaling in transformed cells in culture (PMID: 23656643). | |
III. Representative Data | |
1.WB of CSF3R T618I/BaF3 | |
2. Anti-proliferation assay | |
Figure 2. Anti-proliferation assay of three reference compounds on the CSF3R T618I/BaF3. |